• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对印度裔人群的冠心病多基因风险评分评估。

Polygenic Risk Score Assessment for Coronary Artery Disease in Asian Indians.

机构信息

Department of Pediatrics, Section of Genetics, College of Medicine, University of Oklahoma Health Sciences Center, 940 Stanton L. Young Blvd., Rm 317 BMSB, Oklahoma City, OK, 73104, USA.

Guru Nanak Dev University, Amritsar, Punjab, India.

出版信息

J Cardiovasc Transl Res. 2024 Oct;17(5):1086-1096. doi: 10.1007/s12265-024-10511-z. Epub 2024 Apr 24.

DOI:10.1007/s12265-024-10511-z
PMID:38658478
Abstract

We evaluated the performance of various polygenic risk score (PRS) models derived from European (EU), South Asian (SA), and Punjabi Asian Indians (AI) studies on 13,974 subjects from AI ancestry. While all models successfully predicted Coronary artery disease (CAD) risk, the AI, SA, and EU + AI were superior predictors and more transportable than the EU model; the predictive performance in training and test sets was 18% and 22% higher in AI and EU + AI models, respectively than in EU. Comparing individuals with extreme PRS quartiles, the AI and EU + AI captured individuals with high CAD risk showed 2.6 to 4.6 times higher efficiency than the EU. Interestingly, including the clinical risk score did not significantly change the performance of any genetic model. The enrichment of diversity variants in EU PRS improves risk prediction and transportability. Establishing population-specific normative and risk factors and inclusion into genetic models would refine the risk stratification and improve the clinical utility of CAD PRS.

摘要

我们评估了来自欧洲(EU)、南亚(SA)和旁遮普印度裔(AI)研究的各种多基因风险评分(PRS)模型在 13974 名 AI 血统个体中的表现。虽然所有模型都成功地预测了冠心病(CAD)风险,但 AI、SA 和 EU+AI 是更好的预测因子,比 EU 模型更具可转移性;在训练和测试集中,AI 和 EU+AI 模型的预测性能分别比 EU 模型高 18%和 22%。比较具有极端 PRS 四分位数的个体,AI 和 EU+AI 模型捕捉到的具有高 CAD 风险的个体比 EU 模型的效率高 2.6 至 4.6 倍。有趣的是,包括临床风险评分并没有显著改变任何遗传模型的性能。在 EU PRS 中丰富多样性变异可以提高风险预测和可转移性。建立特定人群的规范和风险因素,并将其纳入遗传模型中,将细化风险分层并提高 CAD PRS 的临床实用性。

相似文献

1
Polygenic Risk Score Assessment for Coronary Artery Disease in Asian Indians.针对印度裔人群的冠心病多基因风险评分评估。
J Cardiovasc Transl Res. 2024 Oct;17(5):1086-1096. doi: 10.1007/s12265-024-10511-z. Epub 2024 Apr 24.
2
Modification of coronary artery disease clinical risk factors by coronary artery disease polygenic risk score.冠状动脉疾病多基因风险评分对冠状动脉疾病临床风险因素的修正。
Med. 2024 May 10;5(5):459-468.e3. doi: 10.1016/j.medj.2024.02.015. Epub 2024 Apr 19.
3
Precision Medicine in Cardiovascular Disease Prevention: Clinical Validation of Multi-Ancestry Polygenic Risk Scores in a U.S. Cohort.心血管疾病预防中的精准医学:美国队列中多血统多基因风险评分的临床验证
Nutrients. 2025 Mar 6;17(5):926. doi: 10.3390/nu17050926.
4
A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.多基因风险评分可改善冠状动脉疾病的风险分层:一项大规模的前瞻性中国队列研究。
Eur Heart J. 2022 May 7;43(18):1702-1711. doi: 10.1093/eurheartj/ehac093.
5
Polygenic Risk Scores in Predicting Coronary Artery Disease in Symptomatic Patients. A Validation Study.多基因风险评分在预测有症状患者的冠状动脉疾病中的作用。一项验证性研究。
J Atheroscler Thromb. 2024 Jul 1;31(7):1058-1071. doi: 10.5551/jat.64623. Epub 2024 Feb 23.
6
Performance of Polygenic Risk Scores for Primary Open-Angle Glaucoma in Populations of African Descent.非洲裔人群中原发性开角型青光眼多基因风险评分的表现
JAMA Ophthalmol. 2025 Jan 1;143(1):7-14. doi: 10.1001/jamaophthalmol.2024.4784.
7
Polygenic risk score portability for common diseases across genetically diverse populations.多基因风险评分在遗传多样性人群中常见疾病的可转移性。
Hum Genomics. 2024 Sep 2;18(1):93. doi: 10.1186/s40246-024-00664-y.
8
Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.基于人群的前瞻性队列研究:东亚常见癌症的多基因风险评分预测。
Elife. 2023 Mar 27;12:e82608. doi: 10.7554/eLife.82608.
9
Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians.验证全基因组多基因风险评分在法裔加拿大人冠状动脉疾病中的作用。
Circ Genom Precis Med. 2019 Jun;12(6):e002481. doi: 10.1161/CIRCGEN.119.002481. Epub 2019 Jun 11.
10
Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease.多基因风险评分增强预测模型与临床风险评分对冠状动脉疾病预测的准确性比较。
JAMA. 2020 Feb 18;323(7):636-645. doi: 10.1001/jama.2019.22241.

引用本文的文献

1
Application of AI in the identification of gastrointestinal stromal tumors: a comprehensive analysis based on pathological, radiological, and genetic variation features.人工智能在胃肠道间质瘤识别中的应用:基于病理、放射学和基因变异特征的综合分析
Front Genet. 2025 Jul 4;16:1555744. doi: 10.3389/fgene.2025.1555744. eCollection 2025.
2
Excess of rare noncoding variants in several type 2 diabetes candidate genes among Asian Indian families.亚洲印度家庭中几种2型糖尿病候选基因存在过量罕见非编码变异。
Commun Med (Lond). 2025 Feb 22;5(1):47. doi: 10.1038/s43856-025-00750-9.

本文引用的文献

1
Use of Polygenic Risk Scores for Coronary Heart Disease in Ancestrally Diverse Populations.多基因风险评分在祖源多样化人群中的冠心病应用。
Curr Cardiol Rep. 2022 Sep;24(9):1169-1177. doi: 10.1007/s11886-022-01734-0. Epub 2022 Jul 7.
2
A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study.多基因风险评分可改善冠状动脉疾病的风险分层:一项大规模的前瞻性中国队列研究。
Eur Heart J. 2022 May 7;43(18):1702-1711. doi: 10.1093/eurheartj/ehac093.
3
Polygenic Risk Score for Coronary Artery Disease Improves the Prediction of Early-Onset Myocardial Infarction and Mortality in Men.
冠心病多基因风险评分改善了男性早发性心肌梗死和死亡率的预测。
Circ Genom Precis Med. 2021 Dec;14(6):e003452. doi: 10.1161/CIRCGEN.121.003452. Epub 2021 Oct 21.
4
APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groups.载脂蛋白 C3 基因变异、血清三酰甘油与亚洲印第安人、欧洲人和其他族群的冠心病风险。
Lipids Health Dis. 2021 Sep 21;20(1):113. doi: 10.1186/s12944-021-01531-8.
5
Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data.多基因风险评分与冠状动脉疾病:979286 名参与者数据的荟萃分析。
Atherosclerosis. 2021 Sep;333:48-55. doi: 10.1016/j.atherosclerosis.2021.08.020. Epub 2021 Aug 12.
6
A Bidirectional Mendelian Randomization Study to evaluate the causal role of reduced blood vitamin D levels with type 2 diabetes risk in South Asians and Europeans.一项双向孟德尔随机化研究评估了南亚人和欧洲人血液维生素 D 水平降低与 2 型糖尿病风险之间的因果关系。
Nutr J. 2021 Jul 27;20(1):71. doi: 10.1186/s12937-021-00725-1.
7
Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses.多基因风险评分在心血管风险预测中的应用:一项队列研究和建模分析。
PLoS Med. 2021 Jan 14;18(1):e1003498. doi: 10.1371/journal.pmed.1003498. eCollection 2021 Jan.
8
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
9
Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South Asians.南亚人群冠状动脉疾病全基因组多基因风险评分的验证。
J Am Coll Cardiol. 2020 Aug 11;76(6):703-714. doi: 10.1016/j.jacc.2020.06.024.
10
Tutorial: a guide to performing polygenic risk score analyses.教程:多基因风险评分分析操作指南。
Nat Protoc. 2020 Sep;15(9):2759-2772. doi: 10.1038/s41596-020-0353-1. Epub 2020 Jul 24.